Year |
Citation |
Score |
2020 |
Paquin A, Visram A, Kumar SK, Gertz MA, Cantwell H, Buadi FK, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Lust JA, Russell SJ, ... Leung N, et al. Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma. Blood Cancer Journal. 10: 87. PMID 32859899 DOI: 10.1038/S41408-020-00353-8 |
0.308 |
|
2020 |
Sidana S, Muchtar E, Sidiqi MH, Jevremovic D, Dispenzieri A, Gonsalves W, Buadi F, Lacy MQ, Hayman SR, Kourelis T, Kapoor P, Go RS, Warsame R, Leung N, Rajkumar SV, et al. Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis. American Journal of Hematology. PMID 32010993 DOI: 10.1002/Ajh.25746 |
0.308 |
|
2020 |
Milani P, Leung N, Kastritis E, Schönland S, Hegenbart U, Bridoux F, Joly F, Tuchman SA, Jimenez-Zepeda V, Ravichandran S, Lee H, Berno T, Merlini G, Palladini G, Wechalekar AD. Light Chain Deposition Disease: First Analysis of an International Study in 359 Patients Blood. 136: 33-34. DOI: 10.1182/BLOOD-2020-141662 |
0.31 |
|
2019 |
Tandon N, Sidana S, Rajkumar SV, Gertz MA, Buadi FK, Lacy MQ, Kapoor P, Gonsalves WI, Dispenzieri A, Kourelis TV, Warsame R, Dingli D, Fonder AL, Hayman SR, Hobbs MA, ... ... Leung N, et al. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma. Blood Advances. 3: 744-750. PMID 30824418 DOI: 10.1182/Bloodadvances.2018022806 |
0.306 |
|
2018 |
Sidiqi MH, Buadi FK, Dispenzieri A, Warsame R, Lacy MQ, Dingli D, Leung N, Gonsalves WI, Kapoor P, Kourelis TV, Hogan WJ, Kumar SK, Gertz MA. Autologous Stem Cell Transplant for IgM Associated AL amyloidosis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30529461 DOI: 10.1016/j.bbmt.2018.12.003 |
0.319 |
|
2018 |
Saba ES, Cambron JC, Go RS, Leung N, Sridharan M. Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy Blood. 132: 4978-4978. DOI: 10.1182/BLOOD-2018-99-117723 |
0.317 |
|
2017 |
Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, Grogan M, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, et al. Improved outcomes for newly diagnosed AL amyloidosis over the years 2000-2014: cracking the glass ceiling of early death. Blood. PMID 28126928 DOI: 10.1182/Blood-2016-11-751628 |
0.302 |
|
2017 |
Warsame R, Laplant B, Laumann K, Kumar SK, Gertz MA, Kyle RA, Lacy MQ, Dingli D, Leung N, Buadi FK, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, et al. Long-Term Outcomes of IMiD Based Trials in Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Pooled Analysis Blood. 130: 1833-1833. DOI: 10.1182/Blood.V130.Suppl_1.1833.1833 |
0.306 |
|
2016 |
Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, ... ... Leung N, et al. Outcomes of patients with renal monoclonal immunoglobulin deposition disease. American Journal of Hematology. PMID 27501122 DOI: 10.1002/Ajh.24528 |
0.327 |
|
2016 |
Vignon M, Javaugue V, Alexander MP, El-Karoui K, Karras A, Roos-Weil D, Royer B, Asli B, Knebelmann B, Touchard G, Jaccard A, Arnulf B, Bridoux F, Leung N, Fermand JP. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome (A retrospective series of 49 patients). Leukemia. PMID 27435002 DOI: 10.1038/leu.2016.195 |
0.334 |
|
2016 |
Hwa YL, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Kourelis TV, Gonsalves WI, Rajkumar SV, Go RS, Leung N, Kapoor P, Dingli D, Kyle RA, Russell S, Lust JA, et al. Induction Therapy Pre-Autologous Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis: A Retrospective Evaluation. American Journal of Hematology. PMID 27341539 DOI: 10.1002/Ajh.24453 |
0.312 |
|
2015 |
Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Kapoor P, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust S, Kyle RA, et al. Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer Journal. 5: e296. PMID 25794132 DOI: 10.1038/bcj.2015.20 |
0.321 |
|
2015 |
Hwa YL, Kumar SK, Lacy MQ, Gertz MA, Buadi F, Rajkumar SV, Go RS, Leung N, Kapoor P, Dingli D, Russell SJ, Lust JA, Hayman SR, Kourelis T, Dispenzieri A. Impact of Bone Marrow Plasmacytosis on Outcome in Patients with AL Amyloidosis Following Autologous Stem Cell Transplant Blood. 126: 3177-3177. DOI: 10.1182/Blood.V126.23.3177.3177 |
0.305 |
|
2013 |
Leung N, Glavey SV, Kumar S, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Gertz MA. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? Haematologica. 98: 988-92. PMID 23729727 DOI: 10.3324/Haematol.2012.079210 |
0.325 |
|
2013 |
Paludo J, Painuly U, Kumar S, Buadi F, Hayman SR, Lacy MQ, Dispenzieri A, Lust JA, Dingli D, McCurdy A, Russell SJ, Leung N, Zeldenrust SR, Rajkumar V, Gertz MA, et al. Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience Blood. 122: 3119-3119. DOI: 10.1182/BLOOD.V122.21.3119.3119 |
0.302 |
|
2013 |
A Gertz M, Hayman SR, Dingli D, Dispenzieri A, Kapoor P, Kumar SK, Lacy MQ, Leung N, Lin Y, Lust JA, Mikhael JR, Rajkumar SV, Russell SJ, Zeldenrust SR, Kyle R, et al. Therapy Related MDS/AML In Multiple Myeloma Patients In The Era Of Novel Agents Blood. 122: 3117-3117. DOI: 10.1182/Blood.V122.21.3117.3117 |
0.309 |
|
2012 |
Warsame R, Bang S, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Lust JA, Russell S, Witzig TE, Kyle RA, Leung N, Zeldenrust SR, Rajkumar SV, Gertz MA, et al. Outcomes and Treatments of Relapsed AL Amyloidosis Following Stem Cell Transplant Blood. 120: 1858-1858. DOI: 10.1182/Blood.V120.21.1858.1858 |
0.325 |
|
2011 |
Leung N, Kumar S, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Glavey SV, Gertz MA. The Timing of Acute Renal Failure Strongly Affects Survival of Immunoglobulin Light Chain (AL) Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation, Blood. 118: 4120-4120. DOI: 10.1182/blood.v118.21.4120.4120 |
0.309 |
|
2010 |
Gertz MAA, Lacy M, Dispenzieri A, Kumar S, Buadi F, Dingli D, Ansell SM, Gastineau D, Inwards DJ, Johnston PB, Litzow MR, Micallef I, Porrata L, Leung N, Wolf R, et al. Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients Blood. 116: 3557-3557. DOI: 10.1182/BLOOD.V116.21.3557.3557 |
0.305 |
|
2007 |
Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Leung N, Gastineau DA. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplantation. 39: 605-11. PMID 17369867 DOI: 10.1038/sj.bmt.1705627 |
0.307 |
|
2005 |
Lorenz EC, Gertz MA, Fervenza FC, Leung N. Long-Term Renal Outcome of Autologous Stem Cell Transplantation in Light Chain Deposition Disease. Blood. 106: 5518-5518. DOI: 10.1182/BLOOD.V106.11.5518.5518 |
0.313 |
|
Show low-probability matches. |